The haemophilia treatment landscape is fast evolving, with many new and innovative therapies in the final stages of development or being marketed in Europe. To help our members navigate these changes, the EHC has developed a publication, the Novel Treatment Review issued twice a year with the latest therapeutic developments. The Novel Treatment Review Committee members support EHC staff in developing the content of this newsletter.
This committee is composed of:
Paul Batty
University College London, UK
Prof Jan Blatny
EHC MAG, Czechia
Prof Ana Boban
EHC MAG, Croatia
MD Panagiotis Christoforou
EHC SC Member, Greek NMO
Miguel Crato
EHC President, Portuguese NMO
Mariëtte Driessens
Dutch NMO
Radoslaw Kaczmarek
Polish NMO
Ilmar Kruis
Dutch NMO
Dr Maria Elisa Mancuso
EHC MAG, Italy
Brian O’Mahony
EHC MASAG member, Irish NMO
Prof Johannes Oldenburg
EHC MAG, Germany
David Page
Canadian Haemophilia Society
Uwe Schlenkrich
Germany
In addition to these volunteers, the EHC Novel Treatment Review is also edited by some EHC MAG members.